Preferred Name |
loteprednol |
|
Synonyms |
chloromethyl 11beta,17alpha-dihydroxy-3-oxoandrosta-1,4-diene-17beta-carboxylate chloromethyl (1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-14-carboxylate loteprednol C21H27ClO5 |
|
ID |
http://purl.obolibrary.org/obo/CHEBI_50848 |
|
activates | ||
ATCCode |
S01BA14 |
|
CASRN |
82034-46-6 |
|
DBBrand |
alrex lotemax loteflam |
|
DBname |
loteprednol |
|
DBSynonym |
loteprednol etabonate |
|
Definition |
An androstanoid that has formula C21H27ClO5. |
|
has effect |
http://purl.obolibrary.org/obo/OAE_0000081 http://purl.obolibrary.org/obo/OAE_0000377 http://purl.obolibrary.org/obo/OAE_0001509 http://purl.obolibrary.org/obo/OAE_0000373 http://purl.obolibrary.org/obo/OAE_0000312 http://purl.obolibrary.org/obo/OAE_0000510 http://purl.obolibrary.org/obo/OAE_0000645 http://purl.obolibrary.org/obo/OAE_0000789 http://purl.obolibrary.org/obo/OAE_0000329 http://purl.obolibrary.org/obo/OAE_0000343 |
|
has pharmacological target | ||
has role | ||
InChI |
InChI=1S/C21H27ClO5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,18(25)27-11-22)20(15,2)10-16(24)17(14)19/h5,7,9,14-17,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,17+,19-,20-,21-/m0/s1 |
|
InChIKey |
InChIKey=YPZVAYHNBBHPTO-MXRBDKCISA-N |
|
label |
loteprednol |
|
prefixIRI |
obo2:CHEBI_50848 |
|
prefLabel |
loteprednol |
|
SMILES |
[H][C@@]12CCC3=CC(=O)C=C[C@]3(C)[C@@]1([H])[C@@H](O)C[C@@]1(C)[C@@]2([H])CC[C@]1(O)C(=O)OCCl [H][C@@]12CC[C@](O)(C(=O)OCCl)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C |
|
Synonym |
chloromethyl 11beta,17alpha-dihydroxy-3-oxoandrosta-1,4-diene-17beta-carboxylate chloromethyl (1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-14-carboxylate loteprednol C21H27ClO5 |
|
xref |
DrugBank:DB00873 CASRN:129260-79-3 PharmGKB:PA164764569 Wikipedia:http://en.wikipedia.org/wiki/Loteprednol National Drug Code Directory:24208-299-25 ChEBI:50848 |
|
subClassOf |